Former Philips Executive Joins to Accelerate Commercial Strategy and Market GrowthSARASOTA, Fla.--(BUSINESS WIRE)--PaceMate®, a market-leading cardiac remote monitoring and cardiac…
NORTHAMPTON, MA / ACCESSWIRE / May 14, 2024 / Olivia Sloan was pursuing a career in health policy and research…
PEORIA, IL / ACCESSWIRE / May 14, 2024 / OSF HealthCare, a health system in Illinois and Michigan, has joined…
SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused…
Apellis received $375 million in funding at close, with ability to access an additional $100 millionMajority of initial proceeds used…
Conference Call and Webcast Today at 4:30 p.m. ETDevelopment Program Highlights and Anticipated 2024 Milestones Ovaprene® hormone-free monthly intravaginal contraceptive…
– Gained alignment with U.S. Food and Drug Administration (FDA) on brilaroxazine clinical trials for New Drug Application (NDA) submission…
Welcomes clients and members to its best-in-class platformDRAPER, Utah, May 14, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (Nasdaq: HQY) ("HealthEquity"),…
PALO ALTO, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage…
Scope of presentation included trial design, rationale, and blinded baseline data on first 50 patients randomized into the Phase II…